2008 Equity Research

print this page

Please see our legal disclaimers within this disclosure section on the web site and/or on the last page of each company review or update. Past research reviews should not be relied upon for any purpose. Research reviews speak only as of the date of the review, and at any time thereafter may no longer be factually accurate and may not reflect our analyst's views on any security.

2008 Reports
		Neurobiological Technologies, Inc. (NTII: NASDAQ) 05.15.08 It’s all about Viprinex; Interim Results are Due in First Half of FY09 for Realization of Greater Shareholder Value.
		ART Advanced Research Technologies, Inc. (ARA.TO, TSX) 03.30.08 Shaking the Tree; Sales Growth Continues Accentuating Gross Margins While Efficiencies Reform the Burn Rate.
		Neurobiological Technologies, Inc. (NTII: NASDAQ) 02.13.08 When You Review Stroke Treatments, Look at One Stroke Drug at a Time; Each One Is Different.